第三波COVID - 19对慢性丙型肝炎患者的影响

Q4 Medicine

JAPANESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS Pub Date : 2020-08-01 DOI:10.33597/jcpt-01-id1003

Daniela Mariano Carvalho-Louro

{"title":"第三波COVID - 19对慢性丙型肝炎患者的影响","authors":"Daniela Mariano Carvalho-Louro","doi":"10.33597/jcpt-01-id1003","DOIUrl":null,"url":null,"abstract":"Letter to EditorIn the practical clinical of Hepatology, the focus of daily life has been the treatment of patients with severe liver diseases, such as cirrhosis and liver cancer. Of all the liver diseases responsible for cirrhosis development, hepatitis C had made the most treatment progress. In a few years, it evolved from drugs with low efficacy and many side effects to highly safe medications with high cure rates.For hepatologists who manage critically ill patients with advanced stages of liver diseases, finding an effective Hepatitis C drug was a great encouragement, a huge motivation to continue believing in clinical research.","PeriodicalId":14602,"journal":{"name":"JAPANESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Impact of the Third Wave of COVID 19 in Patients with Chronic Hepatitis C\",\"authors\":\"Daniela Mariano Carvalho-Louro\",\"doi\":\"10.33597/jcpt-01-id1003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Letter to EditorIn the practical clinical of Hepatology, the focus of daily life has been the treatment of patients with severe liver diseases, such as cirrhosis and liver cancer. Of all the liver diseases responsible for cirrhosis development, hepatitis C had made the most treatment progress. In a few years, it evolved from drugs with low efficacy and many side effects to highly safe medications with high cure rates.For hepatologists who manage critically ill patients with advanced stages of liver diseases, finding an effective Hepatitis C drug was a great encouragement, a huge motivation to continue believing in clinical research.\",\"PeriodicalId\":14602,\"journal\":{\"name\":\"JAPANESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS\",\"volume\":\"6 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAPANESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33597/jcpt-01-id1003\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAPANESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33597/jcpt-01-id1003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

在肝病临床实践中，日常生活的重点一直是肝硬化、肝癌等严重肝病患者的治疗。在所有导致肝硬化发展的肝病中，丙型肝炎的治疗进展最大。在几年的时间里，它从低疗效和许多副作用的药物发展到高治愈率的高度安全的药物。对于管理晚期肝病重症患者的肝病学家来说，找到一种有效的丙型肝炎药物是一个巨大的鼓励，是继续相信临床研究的巨大动力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The Impact of the Third Wave of COVID 19 in Patients with Chronic Hepatitis C

Letter to EditorIn the practical clinical of Hepatology, the focus of daily life has been the treatment of patients with severe liver diseases, such as cirrhosis and liver cancer. Of all the liver diseases responsible for cirrhosis development, hepatitis C had made the most treatment progress. In a few years, it evolved from drugs with low efficacy and many side effects to highly safe medications with high cure rates.For hepatologists who manage critically ill patients with advanced stages of liver diseases, finding an effective Hepatitis C drug was a great encouragement, a huge motivation to continue believing in clinical research.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

JAPANESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS Medicine-Pharmacology (medical)

CiteScore

0.20

自引率

0.00%

发文量